Zihipp Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 4

Employees
  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.41M

  • Investors
  • 1

Zihipp General Information

Description

Developer of obesity therapies designed to provide assistance in losing weight. The company's therapies are offered through research and development on the reduction of diabetes to develop a remedy for obesity, enabling patients to get an absolute cure of weight gain caused by diabetic promoters.

Contact Information

Website
www.zihipp.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Biotechnology
Primary Office
  • 52 Princes Gate
  • Exhibition Road
  • London SW7 2PG
  • England, United Kingdom
+44 020 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zihipp Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC (Series A) 22-Jan-2020 $4.41M 00.000 000.00 Completed Clinical Trials - Phase 1
To view Zihipp’s complete valuation and funding history, request access »

Zihipp Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
To view Zihipp’s complete cap table history, request access »

Zihipp Executive Team (2)

Name Title Board Seat Contact Info
James Minnion Chief Scientific Officer
Stephen Bloom Executive Chairman
To view Zihipp’s complete executive team members history, request access »

Zihipp Board Members (3)

Name Representing Role Since
Govind Pindoria Ph.D Self Board Member 000 0000
Maha Barakat Zihipp Board Member 000 0000
Stephen Bloom Zihipp Executive Chairman 000 0000
To view Zihipp’s complete board members history, request access »

Zihipp Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zihipp Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mubadala Investment Company Sovereign Wealth Fund Minority 000 0000 000000 0
To view Zihipp’s complete investors history, request access »

Zihipp Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Jan-2021 00000 0000 Drug Discovery 0000000 0
To view Zihipp’s complete investments history, request access »